You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
Key Points Every day, 800 women die as a result of pregnancy or childbirth, and an additional 16,000 develop severe and long-lasting complications. Every day, 8000 newborn infants die and 7000 are stillborn, and more than half of these deaths…
Key Points In Roe v. Wade (1973), the U.S. Supreme Court determined that a fundamental “right to privacy existed in the Fourteenth Amendment’s concept of personal liberty” that is “broad enough to encompass a woman’s decision whether or not to…
Key Points A proportion of adverse obstetric events have been shown to be preventable; this proportion varies with the clinical circumstances. Although multiple factors have been associated with the occurrence of adverse obstetric events, issues with communication have been implicated…
Key Points Mental health is fundamental to health. To the extent that maternal biopsychosocial exposures with negative impact on pregnancy outcomes can be diminished, eliminated, or replaced with positive factors, the risk of poor pregnancy outcome can be reduced. Major…
Key Points Overall, without screening and treatment, 85% of neonatal GBS infections are early in onset and result from transmission from a colonized mother. All pregnant women should be cultured for cervicovaginal GBS at 35 to 37 weeks’ gestation. Culture-positive…
Key Points Rubella immunization and HBV and HIV infection screening is standard. HIV screening should be performed via an “opt out” approach, and in high prevalence areas, repeat screening in the third trimester should be considered. Varicella screening may be…
Key Points All pregnant women younger than 25 years or those at increased risk should be screened for Chlamydia and gonorrhea during pregnancy. Women younger than 25 and those at high risk for sexually transmitted infections should be rescreened for…